跳至主要内容
临床试验/NCT03799367
NCT03799367已完成不适用

The Feasibility of Drug Delivery to Infants During Breastfeeding (FEDD)

Cambridge University Hospitals NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2018年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
26
试验地点
1
主要终点
Detection of the change in vitamin B12 concentration in the infants' blood 6-8 hours following vitamin B12 delivery from a nipple shield device during breastfeeding

研究概览

简要总结

Parents commonly find giving medicines to babies, using oral syringes or spoons, difficult and emotionally stressful. In developing countries, additional stress arises due to hygiene difficulties and the lack of clean water. To overcome these challenges and encourage breastfeeding, we have developed the concept of a Therapeutic Nipple Shield, a delivery system that makes it possible to give medicine and nutrients to babies during breastfeeding. It consists of a silicone nipple shield that allows the release of medicine/nutrients into human milk during the feed. Presentations of a prototype to parents and staff at the Rosie Hospital was very positive, and encouraged this clinical study. This study aims to give a vitamin B12 supplement to babies during breastfeeding. The supplement will be placed into a nipple shield, both of which are commercially available, and the mother will breastfeed her baby as usual. Before and after the feed, we will 1) collect a small blood sample from the baby to see whether the vitamin levels in the infant have increased, 2) ask the mother to participate in two short interviews about her expectations and experiences using the Therapeutic Nipple Shield.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
7 Days 至 12 Months(Child)
性别
All
接受健康志愿者

入选标准

  • No known allergy or hypersensitivity against any ingredient used in the study Infant aged up to 12 months Confident breastfeeder (exclusively or non-exclusively)

排除标准

  • The participant may not enter the study if ANY of the following apply:
  • Not confident at breastfeeding
  • Infant not feeding properly
  • Allergy or hypersensitivity against any ingredient of the commercially available Methylcobalamin Vitamin B12 Tablets (Just Vitamins Ltd, UK) used in the study (infant or mother)
  • Medical conditions that could negatively influence swallowing, and thus breastfeeding

结局指标

主要结局

Detection of the change in vitamin B12 concentration in the infants' blood 6-8 hours following vitamin B12 delivery from a nipple shield device during breastfeeding

时间窗: Blood sampling base line and 6-8 hours post feed

Two infant blood samples will be taken - one base line and one post intervention

次要结局

  • Qualitative assessment of impact on maternal expectation, experience and acceptability(Interviews will be conducted prior to and post interventional feed and will last about 30-50 min.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kathryn Beardsall

University Lecturer, University of Cambridge

Cambridge University Hospitals NHS Foundation Trust

研究点 (1)

Loading locations...

相似试验